Cosmetic Laser Dermatology Medical Director Leads Promising Acne Research Study
Mitchel Goldman, MD, Medical Director of Cosmetic Laser Dermatology and coordinating investigator of a groundbreaking clinical study, shares his enthusiasm about the potential breakthrough for acne treatment. “Ameluz® PDT has shown significant benefits in other skin conditions, and we expect it will become a valuable treatment option for patients with moderate to severe acne,” explained Dr. Goldman.
The study represents hope for patients who currently manage acne with treatments that often involve considerable costs, side effects, and lengthy treatment periods. “Expanding Ameluz® to treat acne would mark an important advancement for both dermatologists and patients,” Dr. Goldman noted. “We’re looking forward to the study results with great anticipation.”
This research exemplifies Cosmetic Laser Dermatology’s commitment to advancing dermatological treatments through clinical innovation, continuing our tradition of contributing to breakthrough therapies that benefit patients worldwide.
